Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Ministry of Health, Rhineland-Palatinate, Germany
Ministry of Economics, Rhineland-Palatinate, Germany
German Federal Ministry of Education and Research
Boehringer Ingelheim
Daiichi Sankyo Europe, GmbH
Sanofi
IMO Institut GmbH
PortaVita BV
The German Heart Foundation
Bayer
Information provided by (Responsible Party):
Philipp Wild, MD, MSc, Johannes Gutenberg University Mainz
ClinicalTrials.gov Identifier:
NCT01809015
First received: March 8, 2013
Last updated: May 14, 2014
Last verified: May 2014